Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Man.. they started to create this Final miles BS since early 2018
Thank god they weeded out other shell co.... GLTA.
Watch there be more
“FINAL MILES CO”popping up.
Is a scam. Don’t believe the hype.
39% is held by institutions.
This ain’t going nowhere but UP.
Give it an few months.
Really... ??
Spoke too soon perhaps...
If a company closes below a $1/share bid price for 30 consecutive days, the Nasdaq sends the company a written notice. The notice states that the company is no longer in compliance with its continued listing requirements and has 180 days to regain compliance. Otherwise, the company will face delisting
a RS is silly.. They have time.
You can’t trade PS on extended hours..
Two days of hard selling... I think there going to be a spike soon.
By Michael Dabaie
Novavax Inc. (NVAX) shares were down 67% to 70 cents in heavy volume Thursday after a study missed its primary objective.
The late stage biotechnology company said earlier that a global Phase 3 clinical trial of ResVax to prevent respiratory syncytial virus in infants didn't meet primary objective of prevention of medically significant RSV lower respiratory tract infection.
The trial showed efficacy against a secondary objective on RSV LRTI hospitalization.
The company said its next step is to meet with regulatory authorities to discuss licensure pathways.
The study is supported by an $89.1 million grant from the Bill & Melinda Gates Foundation.
Write to Michael Dabaie at michael.dabaie@wsj.com
(END) Dow Jones Newswires
February 28, 2019 13:25 ET (18:25 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
The study is supported by an $89.1 million
grant from the "Bill & Melinda Gates Foundation".
I doubt this a scam...
FDA commissioner Scott Gottlieb announced he will resign,
he pushed to spur the development of new drugs and with his absence, there is concern in the market.
That’s even better... we’ll see...
Latest Earnings Met Consensus (Q3 ending 09/2018) Next Earnings Announcement
Q3 Non-GAAP earnings
Announced November 7, 2018 -$0.12 Q3 Estimate range
of 6 analysts -$0.15 to -$0.09 Q4 Earnings
will announce (Unconfirmed) March 8, 2019
.50!, here we come!!
3/8 Friday after the bell.
This year has us closer to .0001.
Fixed it for you.
“we will get a knowledgeable healthcare investor, in the absence of a major marketing partner”
Can someone enlighten me.....
“Average rating:5out of5stars, based on”0”reviews”..
you lost me at hello..
I think they will have you as a customer for one more year, unless you have more kids.
By fri, $2200.
CEO IS OFF THE HOOK!
LET THE BULL RUN BEGIN!!!
Keep in mind, amazon “prime” is where the money’s at.
Don’t try to make money selling on amazon, you have a better experience at fleabay.
.0002!!! Rack it up, It won’t last!
All for One & One for All!!!
Bingo!
One tweet costed 40mil.
Twitter is doing it all wrong, they should start charging per tweet.
You can’t short penny stocks...
shorting a penny stock cost more than the share itself.
Better rack up now!! You ain’t going to see .0002 anymore!!!
The three musketeers are die hard fans.
They can’t seem to get out of that tunnel vision.
10k in volume... you guys are going to moon for sure.
Hahhaha $50 volume today.. too funny.
They won’t.
CERTIFICATION & NOTICE OF TERMINATION OF REGISTRATION
Form15 Effective on 7/12/18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File No. 333-197756
Bemax, Inc.
(Exact name of registrant as specified in its charter)
625 Silver Oak Drive
Dallas, GA
707-401-1809
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, par value $0.0001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) o
Rule 12g-4(a)(2) o
Rule 12h-3(b)(1)(i) ?
Rule 12h-3(b)(1)(ii) ?
Rule 15d-6 ?
Approximate number of holders of record as of the certification or notice date: 43
Pursuant to the requirements of the Securities Exchange Act of 1934, BEMAX INC., has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: July 12, 2018
By: /s/ Taiwo Aimasiko
Name: Taiwo Aimasiko
Title: CEO
Dates Referenced Herein
This ‘15-15D’ Filing Date Other Filings
Filed on / Effective on: 7/12/18
I’m sure you didn’t hit the button.
There other one I just saw...
now there 3 and counting.
I agree, Something don’t seem right around here.
Something is happening to the shares&earnings... please tell us why, please...!?
Can I see bem@x shares & earning chart, Please?
I need it for DD.
Oh is coming already, Get ready little cat.
CERTIFICATION & NOTICE OF TERMINATION OF REGISTRATION
Form15 Effective on 7/12/18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File No. 333-197756
Bemax, Inc.
(Exact name of registrant as specified in its charter)
625 Silver Oak Drive
Dallas, GA
707-401-1809
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock, par value $0.0001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty
to file reports under Section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) o
Rule 12g-4(a)(2) o
Rule 12h-3(b)(1)(i) ?
Rule 12h-3(b)(1)(ii) ?
Rule 15d-6 ?
Approximate number of holders of record as of the certification or notice date: 43
Pursuant to the requirements of the Securities Exchange Act of 1934, BEMAX INC., has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: July 12, 2018
By: /s/ Taiwo Aimasiko
Name: Taiwo Aimasiko
Title: CEO
Dates Referenced Herein
This ‘15-15D’ Filing Date Other Filings
Filed on / Effective on: 7/12/18